BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32525556)

  • 1. Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Routh JC; Dasgupta R; Chi YY; Shnorhavorian M; Tian J; Walterhouse DO; Breneman J; Wolden SL; Arndt CA; Hawkins DS; Rodeberg DA
    Int J Cancer; 2020 Dec; 147(11):3168-3176. PubMed ID: 32525556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal lymph node staging in paratesticular rhabdomyosarcoma-are we meeting expectations?
    Hamilton EC; Miller CC; Joseph M; Huh WW; Hayes-Jordan AA; Austin MT
    J Surg Res; 2018 Apr; 224():44-49. PubMed ID: 29506850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
    Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE
    Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
    Rogers TN; Seitz G; Fuchs J; Martelli H; Dasgupta R; Routh JC; Hawkins DS; Koscielniak E; Bisogno G; Rodeberg DA
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28938. PubMed ID: 33522706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
    Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
    J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.
    Dang ND; Dang PT; Samuelian J; Paulino AC
    Cancer; 2013 Sep; 119(17):3228-33. PubMed ID: 23744806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.
    Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG
    J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma.
    Goldfarb B; Khoury AE; Greenberg ML; Churchill BM; Smith CR; McLorie GA
    J Urol; 1994 Aug; 152(2 Pt 2):785-7. PubMed ID: 8022014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
    Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
    Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).
    Rogers TN; De Corti F; Burrieza GG; Guérin F; Terwisscha van Scheltinga S; Smeulders N; Craigie R; Jenney M; Kelsey A; Zanetti I; Coppadoro B; De Salvo GL; Bisogno G; Martelli H
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28479. PubMed ID: 32573979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
    Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma.
    Wiener ES; Lawrence W; Hays D; Lobe TE; Andrassy R; Donaldson S; Crist W; Newton W; Johnson J; Gehan E
    J Pediatr Surg; 1994 Feb; 29(2):171-7; discussion 178. PubMed ID: 8176587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
    Breneman J; Meza J; Donaldson SS; Raney RB; Wolden S; Michalski J; Laurie F; Rodeberg DA; Meyer W; Walterhouse D; Hawkins DS
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):720-6. PubMed ID: 22104356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hemiscrotectomy on outcome of patients with embryonal paratesticular rhabdomyosarcoma: results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P.
    Seitz G; Dantonello TM; Kosztyla D; Klingebiel T; Leuschner I; Fuchs J; Koscielniak E;
    J Urol; 2014 Sep; 192(3):902-7. PubMed ID: 24631108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
    Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.